Characterizing DNA methylation patterns driving chemotherapy resistance in ovarian high-grade serous carcinoma

被引：0
|
作者：
Lahtinen, Alexandra
Marchi, Giovanni
Lavikka, Kari
Micoli, Giulia
Holmstrom, Susanna
Pollanen, Elsi
Maarala, Ilari
Afenteva, Daria
Li, Yilin
Muranen, Taru A.
Oikkonen, Jaana
Huhtinen, Kaisa
Virtanen, Anni
Hynninen, Johanna
Hakkinen, Antti
Hautaniemi, Sampsa
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 05期
关键词：
D O I：
10.1158/1538-7445.OVARIAN23-A003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A003
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Evolution of platinum resistance in high-grade serous ovarian cancer
    Cooke, Susanna L.
    Brenton, James D.
    LANCET ONCOLOGY, 2011, 12 (12): : 1169 - 1174
  • [42] A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma
    Sun, Chao-Yang
    Su, Tie-Fen
    Li, Na
    Zhou, Bo
    Guo, En-Song
    Yang, Zong-Yuan
    Liao, Jing
    Ding, Dong
    Xu, Qin
    Lu, Hao
    Meng, Li
    Wang, Shi-Xuan
    Zhou, Jian-Feng
    Xing, Hui
    Weng, Dan-Hui
    Ma, Ding
    Chen, Gang
    ONCOTARGET, 2016, 7 (03) : 3538 - 3547
  • [43] Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer
    Sundar, Raghav
    Tan, David
    Lei, Lim S.
    Chia, Whay-Kuang
    CURRENT CANCER THERAPY REVIEWS, 2016, 12 (01) : 23 - 36
  • [44] Tailored chemotherapy: Innovative deep-learning model customizing chemotherapy for high-grade serous ovarian carcinoma
    Kim, Se Ik
    Park, Sangick
    Ahn, Eunyong
    Kim, Jeunhui
    Jo, Hyuna
    Lee, Juwon
    Cho, Untack
    Lee, Maria
    Lee, Cheol
    Dhanasekaran, Danny N.
    Ahn, Taejin
    Song, Yong Sang
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (09):
  • [45] Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer
    Elorbany, Samar
    Berlato, Chiara
    Carnevalli, Larissa S.
    Maniati, Eleni
    Barry, Simon T.
    Wang, Jun
    Manchanda, Ranjit
    Kzhyshkowska, Julia
    Balkwill, Frances
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [46] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [47] Characterizing recurrent high-grade serous ovarian cancer through wholegenome sequencing
    Christie, Elizabeth L.
    Pattnaik, Swetansu
    Fereday, Sian
    Thorne, Heather
    Bild, Andrea
    Bowtell, David D.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] Patterns of tumor evolution in high grade serous ovarian carcinoma
    Verhaak, Roel G. W.
    Chang, Kyle
    Kim, Hoon
    Carter, Scott L.
    Schultz, Nikolaus
    Zhao, Fengmei
    Shen, Hui
    Laird, Peter
    Sinah, Rileen
    Muzny, Donna
    Reid, Jeff
    Nu, Jiangong
    Drummond, Jennifer
    Getz, Gad
    Levine, Douglas A.
    Wheeler, David A.
    CANCER RESEARCH, 2012, 72
  • [49] Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma
    Santillan, A.
    Kim, Y. W.
    Zahurak, M. L.
    Gardner, G. J.
    Giuntoli, R. L., II
    Shih, I. M.
    Bristow, R. E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (03) : 601 - 606
  • [50] No evidence for PALB2 methylation in high-grade serous ovarian cancer
    Thomas Mikeska
    Kathryn Alsop
    Gillian Mitchell
    David DL Bowtell
    Alexander Dobrovic
    Journal of Ovarian Research, 6
12345